Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
134
datasets available to search
ShareScore release 0.9.0
Dataset results
134 results for “Sofosbuvir”
Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience
ClinicalTrials.gov study NCT02745535. IPD Sharing: NO. Countries: 1. Publications: 0.
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation
ClinicalTrials.gov study NCT01687257. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis
ClinicalTrials.gov study NCT02114151. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients
ClinicalTrials.gov study NCT01054729. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant
ClinicalTrials.gov study NCT02032875. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sofosbuvir Plus Daclatasvir With or Without Ribavirin and Chronic HCV Genotype (GT) 4
ClinicalTrials.gov study NCT04387526. IPD Sharing: NO. Countries: 0. Publications: 1.
Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases
ClinicalTrials.gov study NCT03572140. IPD Sharing: Not stated. Countries: 0. Publications: 6.
Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant
ClinicalTrials.gov study NCT02533934. IPD Sharing: NO. Countries: 1. Publications: 0.
Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
ClinicalTrials.gov study NCT01838590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3
ClinicalTrials.gov study NCT01808248. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1
ClinicalTrials.gov study NCT01994486. IPD Sharing: Not stated. Countries: 1. Publications: 0.
EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C
ClinicalTrials.gov study NCT02097966. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
ClinicalTrials.gov study NCT01713283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection
ClinicalTrials.gov study NCT03487848. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of CDI-31244 in Combination With Sofosbuvir (SOF) and Velpatasvir (VEL)
ClinicalTrials.gov study NCT03501550. IPD Sharing: NO. Countries: 1. Publications: 0.
Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
ClinicalTrials.gov study NCT02468648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)
ClinicalTrials.gov study NCT02628717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Sofosbuvir-based Regimens in Clinical Practice for the Treatment of Chronic Hepatitis C Virus Infection in India
ClinicalTrials.gov study NCT02592057. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in HCV-infected Children
ClinicalTrials.gov study NCT05854511. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis
ClinicalTrials.gov study NCT02464631. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.